I advocate for cost-effective clinical workflows and high-quality, patient-centered care through AI integration in diagnostic imaging. My focus on early breast cancer detection, bone health, and chronic low back pain treatment aims to optimize patient outcomes and operational efficiency while enhancing the clinical and financial performance of health services organizations.

GE Healthcare (NASDAQ: GEHC), spun-off from the American multinational General Electric Co. (NYSE: GE), is a leading global manufacturer of diagnostic-imaging and critical-care medical equipment with a wide range of healthcare applications.Oversaw growth and profitability of the Radiology, Breast, and Skeletal Health businesses across the CALA-North Latin American subregion, encompassing 38 countries (Andean, Central American, and Caribbean). Reported to the Regional Product Director for Latin America in São Paulo, Brazil.• Launched a groundbreaking digital mammography system that prioritized patient comfort and enhanced diagnostic accuracy through deep-learning technology, leading to swift adoption in major hospitals and outpatient centers.• Spearheaded the first global pilot of the Breast One Stop Clinic business model in Colombia, including the purchase of mammography systems; this model is set for replication across other Latin American clients.• Developed a competitive strategy for mobile mammography, leveraging consultative selling, which resulted in the acquisition of three mobile mammography systems for the National Panamanian project Love on Wheels, aimed at improving early breast cancer diagnosis in remote areas.

AGFA Healthcare, a division of Agfa-Gevaert Group (EBR: AGFB), is a leading provider of comprehensive diagnostic-imaging management solutions, digital radiology (DR) systems, radiographic film, and printing solutions, for a wide range of public hospitals and private health centers.Managed direct sales of a full product line within key accounts in Santiago, Chile, while overseeing indirect sales through distributors across seven regions in northern Chile. Reported to the Chile Sales Manager.• Achieved significant growth in the digital radiology equipment installed base in assigned accounts across Chile.• Oversaw sales for the Healthcare IT business, facilitating upsells for platform updates, while conducting commercial engagement for new platform implementations.

Ethicon Endo-Surgery is a leading manufacturer of medical devices for surgical procedures in oncology and obesity and is also a main business unit of the MedTech division of the American multinational Johnson & Johnson (NYSE: JNJ), that is a manufacturer of medical, pharmaceutical, and personal care products.Managed product sales for surgical staplers and trocars used in laparoscopic procedures (thoracic, gastrointestinal, colorectal, bariatric). Established strong relationships with key opinion leaders and reported directly to the Regional Line Manager, with indirect reporting to the Regional Sales Manager for Chile, Peru, and Ecuador. • Promoted cost-effective surgical procedures by implementing well-trained techniques that minimized the waste of disposable products, enhancing overall operational efficiency.• Trained at the Ethicon Endo-Surgery Institute in Cincinnati, OH, and recertified as a Trainer at the JNJ Ethicon Institute in São Paulo, Brazil, enhancing product knowledge and training skills.

Synthes is a global leader in bone fracture fixation devices and is currently part of DePuy-Synthes, a Johnson & Johnson MedTech division, headquartered in Oberdorf, Switzerland, and Pennsylvania, USA.Led the design and development of innovative cervical and lumbar spinal prostheses (Class III devices) while directly reporting to the Spine Non-Fusion Leader at the European Development Center.• Managed projects through all phases (modeling, testing, design transfer) to meet design-release milestones, ensuring timely and compliant product launches.• Created product development documentation compliant with national and international regulatory standards for Class III products (EU MDD, US FDA), enabling successful market entry.• Co-authored patents for Intervertebral Disc Prosthesis, contributing to the intellectual property portfolio and enhancing the company’s competitive edge in spinal device innovation.(see: https://patents.justia.com/inventor/mario-gago)